Corbus Pharmaceuticals Holdings (CRBP) Operating Income Growth (1y) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Operating Income Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 100.00% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 12.69% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 75.16% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -347.04% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 1.27% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 80.62% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -40.88% |
| Jun 30, 2025 | -1,297.00% |
| Mar 31, 2025 | -2,023.64% |
| Dec 31, 2024 | 117.62% |
| Sep 30, 2024 | 120.06% |
| Jun 30, 2024 | 119.54% |
| Mar 31, 2024 | 105.94% |
| Dec 31, 2023 | 6.42% |
| Sep 30, 2023 | -15.97% |
| Jun 30, 2023 | 33.64% |
| Mar 31, 2023 | -103.08% |
| Dec 31, 2022 | -7.99% |
| Sep 30, 2022 | 41.04% |
| Jun 30, 2022 | 26.11% |
| Mar 31, 2022 | 44.74% |
| Dec 31, 2021 | 51.96% |
| Sep 30, 2021 | 59.16% |
| Jun 30, 2021 | 56.21% |
| Mar 31, 2021 | 48.42% |
| Dec 31, 2020 | 23.46% |